BCBS Medical Policy Update
March 10, 2021Published February 26, 2021.
- Assays of Genetic Expression in Tumor Tissue as a Technique to Determine Prognosis in Patients with Breast Cancer
- Circulating Tumor DNA Management of Non-Small Cell Lung Cancer (Liquid Biopsy)
- Endoscopic Radiofrequency Ablation or Cryoablation for Barrett Esophagus
- Genetic Testing for Cardiac Ion Channelopathies
- Molecular Analysis for Targeted Therapy or Immunotherapy of Non-Small-Cell Lung Cancer
- Sphenopalatine Ganglion Block for Headache
- Stereotactic Radiosurgery and Stereotactic Body Radiotherapy
Source: https://www.bcbsks.com/